Actively Recruiting
Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones
Led by University of Texas Southwestern Medical Center · Updated on 2025-04-06
25
Participants Needed
1
Research Sites
246 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study tests whether hydroxycitrate, a molecule closely related to citrate, can reduce calcium phosphate stone recurrence.
CONDITIONS
Official Title
Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones
Who Can Participate
Eligibility Criteria
You may qualify if you...
- History of calcium phosphate kidney stones
You will not qualify if you...
- History of recurrent urinary tract infections
- Chronic diarrhea
- Estimated Glomerular Filtration Rate below 45 ml/min/1.73 m2
- History of primary hyperparathyroidism
- Low potassium levels (hypokalemia)
- High potassium levels (hyperkalemia)
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UT Southwestern Medical Center
Dallas, Texas, United States, 75390-8885
Actively Recruiting
Research Team
N
NAIM M MAALOUF, MD
CONTACT
M
Miranda King
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here